The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
(10 - 33) Manufacturing (20 - 21) Manufacture of chemicals and pharmaceuticals 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
450 jobs Number of planned job losses
Announcement Date
1 February 2007
Employment effect (start)
Foreseen end date
31 December 2007
Description
Astra Zeneca announced on 1 February that it will cut 450 jobs at its plant in Södertälje before the end of 2007. Further dismissals could be decided within the company's global redundancy plan, which will affect 3,000 workers worlwide over the next three years. The drug maker, which is facing patent challenges and escalating generic competition, revealed the global redundancy plan as part of a 384 million Euro three-year revamp of its supply chain as it said that sales growth would continue at a slower pace this year.
However, on 28 April it was announced that the 450 affected employees might be offered a job at Scania instead. Scania recently moved some of its production from Falun and Sibbhult to Södertälje. However, after the relocation only 100 of the workers from the two affected units have started to work at Scania in Södertälje and the company is short of staff (Scania is creating 1,200 new jobs in Södertälje). Scania is therefore eventually employing new people and, as it was announced on 28 April 2007, the company will employ by the end of the year the workers who have been affected by restructuring at Astra Zeneca.
Sources
1 February 2007: Report by AstraZeneca
1 February 2007: Sveriges Radio
1 February 2007: International Herald Tribune
28 April 2007: Svenska Dagbladet
Citation
Eurofound (2007), Astra Zeneca, Internal restructuring in Sweden, factsheet number 64889, European Restructuring Monitor. Dublin, https://dev.eurofound.europa.eu/restructuring-events/detail/64889.
This working paper offers a comprehensive methodological overview of the European Restructuring Monitor (ERM) databases. Even though the methodology has not changed over time, new categories have been added, and the way it has been used by researchers and policymakers...
This Eurofound research paper explores key trends in restructuring in recent years, highlighting the companies that announced the largest job losses and job gains in the EU. It builds on an analysis of company announcements recorded in Eurofound’s European Restructuring...
In 2023, thousands of workers in big tech lost their jobs. Meta, Amazon, Google, Apple, Microsoft and Salesforce had been considered to offer good and secure jobs up to this point. Giants of the information and communication technology (ICT) sector,...
In 2024, the automotive sector in the EU came to the fore in public and policy discussions. The focus was on the slowdown in electric vehicle (EV) sales, rising global competition, belated investments in new technologies, and the potential closure...
The more employee monitoring resembles surveillance – with its systematic, continuous and detailed tracking of employees' activities, behaviours or communications – the greater the potential for infringement of both privacy and data protection rights. Although the EU General Data Protection...
Since 2013, Eurofound's ERM database on restructuring-related legislation has been documenting regulatory developments in the Member States of the European Union and Norway which are explicitly or implicitly linked to anticipating and managing change. The most recent update to the...